Form 4 for EVH Evolent Health, Inc.
Accepted 2022-02-01 00:00:00 ET · period of report 2022-02-01 · accession 0001628908-22-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-01 | 2022-02-01 | EVH | Tutewohl Steve | COO | S - Sale+OE | $23.47 | -6,313 | 100.5K | -6% | -$148.2K |
| D | 2022-02-01 | 2022-02-01 | EVH | Tutewohl Steve | COO | M - OptEx | $13.95 | +6,313 | 106.9K | +6% | +$88.1K |
| D | 2022-02-01 | 2022-02-01 | EVH | Tutewohl Steve | COO | M - OptEx | $0.00 | -6,313 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-02-01 | S | D | 6,313 | $23.47 | 100,550 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.80, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F2) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| 2 | Common | Class A Common Stock | 2022-02-01 | M | A | 6,313 | $13.95 | 106,863 | D | — | — | (F2) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| 3 | Derivative | Class A Common Stock Option (right to buy) | 2022-02-01 | M | D | 6,313 | $0.00 | 0 | D | $13.95 · — to 2028-02-01 | 6,313 Class A Common Stock | (F4) The Class A Common Stock Options exercised vested on February 1, 2022. |